abrdn Healthcare Investors·4

Jul 20, 2:34 PM ET

Mahai Chris LaVictoire 4

4 · abrdn Healthcare Investors · Filed Jul 20, 2026

Research Summary

AI-generated summary of this filing

Updated

abrdn Healthcare Investors (HQH) Director Mahai Chris LaVictoire Buys 501 Shares

What Happened

  • Mahai Chris LaVictoire, a director of abrdn Healthcare Investors (HQH), reported a purchase of 501 shares on 2026-07-16. The filing shows the transaction as code "P" (open market or private purchase) at $20.96 per share, for a total reported value of $10,501. This was a straight purchase (an acquisition), which is generally more informative to investors than routine sales.

Key Details

  • Transaction date: 2026-07-16
  • Filing date (Form 4): 2026-07-20 (filed within the required two business days — timely)
  • Price per share: $20.96
  • Shares acquired: 501
  • Total value: $10,501 (reported)
  • Transaction code: P (open market or private purchase per the filing)
  • Shares owned after transaction: not disclosed in the provided filing
  • Footnotes/plan info: none reported in the provided data

Context

  • This report documents a direct purchase by a company director. Purchases can be interpreted as a positive signal because insiders are adding to their holdings, but filings do not state motives. No options, gifts, or tax-withholding events were indicated in the provided filing.

Insider Transaction Report

Form 4
Period: 2026-07-16
Transactions
  • Purchase

    Common Stock

    2026-07-16$20.96/sh+501$10,501501 total
Signature
/s/ Robert Stieger, by POA from Reporting Person|2026-07-20

Documents

1 file
  • 4
    tm2620872-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT